Perrigo Company (PRGO) Stock Forecast, Price Target & Predictions
PRGO Stock Forecast
Perrigo Company stock forecast is as follows: an average price target of $42.00 (represents a 65.29% upside from PRGO’s last price of $25.41) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
PRGO Price Target
PRGO Analyst Ratings
Perrigo Company Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 23, 2024 | Keith Devas | Jefferies | $30.00 | $27.06 | 10.86% | 18.06% |
Jun 13, 2024 | Korinne Wolmeyer | Piper Sandler | $36.00 | $27.84 | 29.31% | 41.68% |
Apr 08, 2024 | Korinne Wolmeyer | Piper Sandler | $39.00 | $31.40 | 24.20% | 53.48% |
Nov 17, 2023 | Korinne Wolfmeyer | Piper Sandler | $37.00 | $30.07 | 23.04% | 45.61% |
Sep 06, 2022 | Jacob Hughes | Wells Fargo | $54.00 | $36.74 | 46.98% | 112.51% |
May 04, 2022 | - | Raymond James | $48.00 | $32.76 | 46.54% | 88.90% |
Perrigo Company Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 4 |
Avg Price Target | - | $30.00 | $35.50 |
Last Closing Price | $25.41 | $25.41 | $25.41 |
Upside/Downside | -100.00% | 18.06% | 39.71% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 13, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Apr 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 03, 2022 | Raymond James | Outperform | Outperform | Hold |
Sep 14, 2022 | Bernstein | - | Market Perform | Downgrade |
Sep 14, 2022 | Guggenheim | - | Neutral | Downgrade |
Sep 14, 2022 | B. Riley Securities | - | Buy | Initialise |
Sep 14, 2022 | Morgan Stanley | - | Equal-Weight | Downgrade |
Sep 14, 2022 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
Sep 14, 2022 | Jefferies | - | Hold | Downgrade |
Sep 14, 2022 | Argus Research | - | Buy | Upgrade |
Perrigo Company Financial Forecast
Perrigo Company Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $1.16B | $1.12B | $1.19B | $1.18B | $1.16B | $1.10B | $1.12B | $1.07B | $1.10B | $1.04B | $981.10M | $1.01B | $1.29B | $1.21B | $1.22B | $1.34B | $1.32B | $1.19B |
Avg Forecast | $1.26B | $1.20B | $1.16B | $1.18B | $1.24B | $1.18B | $1.14B | $1.14B | $1.20B | $1.13B | $1.10B | $1.09B | $1.17B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B | $1.23B | $1.34B | $1.31B | $1.20B |
High Forecast | $1.26B | $1.20B | $1.16B | $1.18B | $1.24B | $1.18B | $1.14B | $1.14B | $1.20B | $1.14B | $1.11B | $1.09B | $1.20B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B | $1.23B | $1.34B | $1.31B | $1.20B |
Low Forecast | $1.26B | $1.20B | $1.16B | $1.18B | $1.24B | $1.18B | $1.14B | $1.14B | $1.20B | $1.11B | $1.08B | $1.09B | $1.14B | $1.20B | $1.18B | $1.17B | $1.20B | $1.14B | $1.06B | $1.06B | $1.10B | $1.05B | $1.02B | $1.02B | $1.32B | $1.24B | $1.23B | $1.34B | $1.31B | $1.20B |
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 0.94% | 1.01% | 1.01% | 0.96% | 0.96% | 1.05% | 1.02% | 1.01% | 0.99% | 0.96% | 0.99% | 0.98% | 0.98% | 0.99% | 1.00% | 1.01% | 0.99% |
Perrigo Company EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-15.50M | $184.10M | $56.80M | $140.10M | $134.00M | $144.70M | $32.30M | $95.90M | $91.30M | $488.30M | $3.60M | $174.70M | $-80.70M | $3.20M | $199.90M | $238.00M | $68.80M | $199.30M |
Avg Forecast | $235.73M | $225.26M | $216.96M | $221.38M | $231.42M | $221.82M | $212.71M | $213.84M | $225.40M | $211.32M | $205.73M | $154.10M | $220.06M | $224.85M | $221.20M | $140.09M | $76.39M | $213.88M | $199.42M | $110.74M | $205.91M | $196.97M | $190.64M | $196.15M | $246.97M | $231.42M | $230.47M | $212.58M | $245.47M | $224.47M |
High Forecast | $235.73M | $225.26M | $216.96M | $221.38M | $231.42M | $221.82M | $212.71M | $213.84M | $225.40M | $213.21M | $208.27M | $184.92M | $225.61M | $225.09M | $221.20M | $168.11M | $91.66M | $213.88M | $199.42M | $132.89M | $205.91M | $196.97M | $190.64M | $235.39M | $246.97M | $231.42M | $230.47M | $255.10M | $245.47M | $224.47M |
Low Forecast | $235.73M | $225.26M | $216.96M | $221.38M | $231.42M | $221.82M | $212.71M | $213.84M | $225.40M | $207.55M | $203.18M | $123.28M | $212.66M | $224.60M | $221.20M | $112.07M | $61.11M | $213.88M | $199.42M | $88.59M | $205.91M | $196.97M | $190.64M | $156.92M | $246.97M | $231.42M | $230.47M | $170.07M | $245.47M | $224.47M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.07% | 0.82% | 0.26% | 1.00% | 1.75% | 0.68% | 0.16% | 0.87% | 0.44% | 2.48% | 0.02% | 0.89% | -0.33% | 0.01% | 0.87% | 1.12% | 0.28% | 0.89% |
Perrigo Company Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-32.30M | $14.20M | $8.40M | $-1.10M | $-12.70M | $-52.10M | $-64.90M | $-1.30M | $32.10M | $-53.90M | $-111.90M | $2.80M | $-175.00M | $-154.60M | $60.60M | $106.40M | $-19.00M | $92.20M |
Avg Forecast | $129.71M | $119.39M | $110.58M | $106.16M | $126.17M | $114.02M | $102.43M | $96.82M | $125.88M | $111.94M | $64.93M | $-4.06M | $113.79M | $85.87M | $70.09M | $-3.69M | $-21.10M | $91.61M | $60.32M | $-2.91M | $77.23M | $89.57M | $81.92M | $42.78M | $137.44M | $115.34M | $120.48M | $95.04M | $146.56M | $127.13M |
High Forecast | $129.71M | $119.39M | $110.58M | $106.16M | $126.17M | $114.02M | $102.43M | $96.82M | $125.88M | $114.67M | $66.01M | $-3.24M | $116.53M | $86.79M | $70.09M | $-2.95M | $-16.88M | $91.61M | $60.32M | $-2.33M | $77.23M | $89.57M | $81.92M | $51.33M | $137.44M | $115.34M | $120.48M | $114.04M | $146.56M | $127.13M |
Low Forecast | $129.71M | $119.39M | $110.58M | $106.16M | $126.17M | $114.02M | $102.43M | $96.82M | $125.88M | $109.21M | $63.86M | $-4.87M | $106.94M | $84.96M | $70.09M | $-4.42M | $-25.31M | $91.61M | $60.32M | $-3.50M | $77.23M | $89.57M | $81.92M | $34.22M | $137.44M | $115.34M | $120.48M | $76.03M | $146.56M | $127.13M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.28% | 0.17% | 0.12% | 0.30% | 0.60% | -0.57% | -1.08% | 0.45% | 0.42% | -0.60% | -1.37% | 0.07% | -1.27% | -1.34% | 0.50% | 1.12% | -0.13% | 0.73% |
Perrigo Company SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $152.50M | $304.00M | $171.10M | $331.50M | $308.60M | $281.00M | $338.10M | $282.30M | $269.30M | $283.60M | $274.30M | $284.20M | $330.00M | $281.00M | $270.00M | $294.50M | $288.60M | $289.40M |
Avg Forecast | $324.05M | $309.66M | $298.25M | $304.32M | $318.14M | $304.93M | $292.41M | $293.97M | $309.85M | $290.50M | $282.81M | $477.00M | $302.52M | $309.09M | $304.08M | $433.63M | $320.43M | $294.02M | $274.14M | $342.79M | $283.06M | $270.77M | $262.08M | $319.10M | $339.51M | $318.12M | $316.83M | $261.71M | $337.45M | $308.57M |
High Forecast | $324.05M | $309.66M | $298.25M | $304.32M | $318.14M | $304.93M | $292.41M | $293.97M | $309.85M | $293.10M | $286.31M | $572.40M | $310.14M | $309.43M | $304.08M | $520.36M | $384.51M | $294.02M | $274.14M | $411.35M | $283.06M | $270.77M | $262.08M | $382.92M | $339.51M | $318.12M | $316.83M | $314.05M | $337.45M | $308.57M |
Low Forecast | $324.05M | $309.66M | $298.25M | $304.32M | $318.14M | $304.93M | $292.41M | $293.97M | $309.85M | $285.31M | $279.31M | $381.60M | $292.35M | $308.75M | $304.08M | $346.91M | $256.34M | $294.02M | $274.14M | $274.23M | $283.06M | $270.77M | $262.08M | $255.28M | $339.51M | $318.12M | $316.83M | $209.37M | $337.45M | $308.57M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.50% | 0.98% | 0.56% | 0.76% | 0.96% | 0.96% | 1.23% | 0.82% | 0.95% | 1.05% | 1.05% | 0.89% | 0.97% | 0.88% | 0.85% | 1.13% | 0.86% | 0.94% |
Perrigo Company EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 | 15 | 8 | 10 | 7 | 10 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.24 | $0.10 | $0.06 | $-0.01 | $-0.09 | $-0.39 | $-0.48 | $-0.01 | $0.24 | $-0.40 | $-0.84 | $0.29 | $-1.29 | $-1.13 | $0.44 | $0.78 | $-0.14 | $0.68 |
Avg Forecast | $0.95 | $0.87 | $0.81 | $0.77 | $0.92 | $0.83 | $0.75 | $0.71 | $0.92 | $0.82 | $0.47 | $0.23 | $0.83 | $0.63 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 | $0.88 | $1.03 | $1.07 | $0.93 |
High Forecast | $0.95 | $0.87 | $0.81 | $0.77 | $0.92 | $0.83 | $0.75 | $0.71 | $0.92 | $0.84 | $0.48 | $0.24 | $0.85 | $0.63 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 | $0.88 | $1.03 | $1.07 | $0.93 |
Low Forecast | $0.95 | $0.87 | $0.81 | $0.77 | $0.92 | $0.83 | $0.75 | $0.71 | $0.92 | $0.80 | $0.47 | $0.23 | $0.78 | $0.62 | $0.51 | $0.43 | $0.70 | $0.67 | $0.44 | $0.42 | $0.56 | $0.65 | $0.60 | $0.57 | $1.00 | $0.84 | $0.88 | $1.03 | $1.07 | $0.93 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.29% | 0.16% | 0.12% | -0.02% | -0.13% | -0.58% | -1.09% | -0.02% | 0.43% | -0.61% | -1.41% | 0.51% | -1.29% | -1.34% | 0.50% | 0.76% | -0.13% | 0.73% |
Perrigo Company Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
PCRX | Pacira BioSciences | $16.45 | $40.00 | 143.16% | Hold |
ELAN | Elanco Animal Health | $12.56 | $26.50 | 110.99% | Buy |
PRGO | Perrigo Company | $25.41 | $42.00 | 65.29% | Hold |
ANIP | ANI Pharmaceuticals | $56.01 | $79.00 | 41.05% | Buy |
AMPH | Amphastar Pharmaceuticals | $50.59 | $66.00 | 30.46% | Buy |
COLL | Collegium Pharmaceutical | $32.72 | $41.50 | 26.83% | Buy |
PBH | Prestige Consumer Healthcare | $73.79 | $82.00 | 11.13% | Buy |
DCPH | Deciphera Pharmaceuticals | $25.59 | $26.32 | 2.85% | Hold |
PAHC | Phibro Animal Health | $22.37 | $18.67 | -16.54% | Buy |
PRGO Forecast FAQ
Is Perrigo Company a good buy?
No, according to 9 Wall Street analysts, Perrigo Company (PRGO) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 44.44% of PRGO's total ratings.
What is PRGO's price target?
Perrigo Company (PRGO) average price target is $42 with a range of $30 to $54, implying a 65.29% from its last price of $25.41. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Perrigo Company stock go up soon?
According to Wall Street analysts' prediction for PRGO stock, the company can go up by 65.29% (from the last price of $25.41 to the average price target of $42), up by 112.51% based on the highest stock price target, and up by 18.06% based on the lowest stock price target.
Can Perrigo Company stock reach $40?
PRGO's average twelve months analyst stock price target of $42 supports the claim that Perrigo Company can reach $40 in the near future.
What are Perrigo Company's analysts' financial forecasts?
Perrigo Company's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.7B (high $4.7B, low $4.7B), average EBITDA is $879.8M (high $879.8M, low $879.8M), average net income is $439.44M (high $439.44M, low $439.44M), average SG&A $1.21B (high $1.21B, low $1.21B), and average EPS is $3.21 (high $3.21, low $3.21). PRGO's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.8B (high $4.8B, low $4.8B), average EBITDA is $899.31M (high $899.31M, low $899.31M), average net income is $465.85M (high $465.85M, low $465.85M), average SG&A $1.24B (high $1.24B, low $1.24B), and average EPS is $3.4 (high $3.4, low $3.4).
Did the PRGO's actual financial results beat the analysts' financial forecasts?
Based on Perrigo Company's last annual report (Dec 2023), the company's revenue was $4.66B, which missed the average analysts forecast of $4.73B by -1.54%. Apple's EBITDA was $151.9M, missing the average prediction of $806.19M by -81.16%. The company's net income was $-12.7M, missing the average estimation of $266.07M by -104.77%. Apple's SG&A was $641.8M, missing the average forecast of $1.35B by -52.44%. Lastly, the company's EPS was $-0.0939, missing the average prediction of $2.4 by -103.92%. In terms of the last quarterly report (Dec 2023), Perrigo Company's revenue was $1.16B, missing the average analysts' forecast of $1.17B by -1.53%. The company's EBITDA was $-15.5M, missing the average prediction of $220.06M by -107.04%. Perrigo Company's net income was $-32.3M, missing the average estimation of $113.79M by -128.38%. The company's SG&A was $152.5M, missing the average forecast of $302.52M by -49.59%. Lastly, the company's EPS was $-0.24, missing the average prediction of $0.83 by -128.92%